Clinical Trials Browser

Phase 2 × pamiparib × Thoracic × Clear all

NCT05483543 2022-08-02

Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy

Phase 2 Unknown

Limited Stage Small Cell Lung Cancer